[CHRS] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
04-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 49.40%
YoY- -88.25%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 32,436 45,352 45,424 60,151 60,115 73,371 82,503 -46.36%
PBT -75,729 -58,870 -86,650 -50,150 -96,084 -45,725 -38,528 56.97%
Tax -949 7,377 6,201 6,137 15,159 5,793 5,801 -
NP -74,780 -66,247 -92,851 -56,287 -111,243 -45,725 -38,528 55.66%
Tax Rate - - - - - - - -
Total Cost 107,216 111,599 138,275 116,438 171,358 119,096 121,031 -7.76%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -230.55 -146.07 -204.41 -93.58 -185.05 -62.32 -46.70 190.21%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.94 -0.85 -1.19 -0.73 -1.44 -0.60 -0.49 54.45%
EPS Diluted -0.94 -0.85 -1.19 -0.73 -1.44 -0.60 -0.49 54.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.